Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1993 2
1995 4
1996 5
1997 1
1998 1
1999 6
2001 3
2002 3
2003 2
2004 8
2005 10
2006 33
2007 14
2008 4
2009 7
2010 7
2011 7
2012 5
2013 9
2014 7
2015 21
2016 10
2017 10
2018 5
2019 11
2020 5
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Results by year
Filters applied: . Clear all
Page 1
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy.
Yurdaydin C, Abbas Z, Buti M, Cornberg M, Esteban R, Etzion O, Gane EJ, Gish RG, Glenn JS, Hamid S, Heller T, Koh C, Lampertico P, Lurie Y, Manns M, Parana R, Rizzetto M, Urban S, Wedemeyer H; Hepatitis Delta International Network (HDIN). Yurdaydin C, et al. Among authors: gish rg. J Hepatol. 2019 May;70(5):1008-1015. doi: 10.1016/j.jhep.2018.12.022. Epub 2018 Dec 27. J Hepatol. 2019. PMID: 30982526 Review.
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
Wooddell CI, Yuen MF, Chan HL, Gish RG, Locarnini SA, Chavez D, Ferrari C, Given BD, Hamilton J, Kanner SB, Lai CL, Lau JYN, Schluep T, Xu Z, Lanford RE, Lewis DL. Wooddell CI, et al. Among authors: gish rg. Sci Transl Med. 2017 Sep 27;9(409):eaan0241. doi: 10.1126/scitranslmed.aan0241. Sci Transl Med. 2017. PMID: 28954926 Free PMC article. Clinical Trial.
RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection.
Yuen MF, Schiefke I, Yoon JH, Ahn SH, Heo J, Kim JH, Lik Yuen Chan H, Yoon KT, Klinker H, Manns M, Petersen J, Schluep T, Hamilton J, Given BD, Ferrari C, Lai CL, Locarnini SA, Gish RG. Yuen MF, et al. Among authors: gish rg. Hepatology. 2020 Jul;72(1):19-31. doi: 10.1002/hep.31008. Epub 2020 Apr 23. Hepatology. 2020. PMID: 31654573 Free PMC article. Clinical Trial.
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients.
Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K. Sasadeusz J, et al. Among authors: gish rg. Clin Liver Dis. 2019 Aug;23(3):493-509. doi: 10.1016/j.cld.2019.04.010. Epub 2019 Jun 6. Clin Liver Dis. 2019. PMID: 31266623 Review.
Drugs in Development for Hepatitis B.
Dawood A, Abdul Basit S, Jayaraj M, Gish RG. Dawood A, et al. Among authors: gish rg. Drugs. 2017 Aug;77(12):1263-1280. doi: 10.1007/s40265-017-0769-2. Drugs. 2017. PMID: 28660478 Free PMC article. Review.
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.
Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K. Sasadeusz J, et al. Among authors: gish rg. Clin Liver Dis. 2019 Aug;23(3):487-492. doi: 10.1016/j.cld.2019.04.009. Epub 2019 Jun 6. Clin Liver Dis. 2019. PMID: 31266622 Review.
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents.
Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K. Sasadeusz J, et al. Among authors: gish rg. Clin Liver Dis. 2019 Aug;23(3):521-534. doi: 10.1016/j.cld.2019.04.012. Epub 2019 Jun 5. Clin Liver Dis. 2019. PMID: 31266625 Review.
190 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page